Delivery Order SPE2DB20D3103-SPE2DB22FP8K0

Award Date 9/12/22
Potential Completion Date 9/13/22
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,135.75 contract is for the supply of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product, with a completion date of July 26, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,793.07, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of February 18, 2025. No set-aside designation was used for this award. In addition to this specific delivery order, AmerisourceBergen holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, with a ceiling value of $1,933.30. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on August 26, 2022, with a ceiling value of $3,165.05 and an ultimate completion date of August 29, 2022. The contract is a Delivery Order with a Firm Fixed Price pricing type. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML, a pharmaceutical product, with a ceiling value of $3,486.18. The contract was awarded on September 27, 2022, with a completion date of September 28, 2022, and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
This federal contract award is for the delivery of OFLOXACIN 0.3% EAR DROPS 10ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $3,750.93. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 20, 2022. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying...
This federal contract award from the Defense Logistics Agency (DLA) is for the delivery of 4557140794 Ofloxacin 0.3% Ear Drops 10ML to the place of performance in Conshohocken, PA. The fixed-price delivery order, valued at $2,808.76, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government...
This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,640.84 contract is for the delivery of Ofloxacin 0.3% ear drops, 5ml, to support DLA Troop Support Medical programs and facilities. No set aside designation was used. Amerisourcebergen Drug Corp, as a prime contractor, has received numerous federal contract...
This federal contract award is for the delivery of Ofloxacin 0.3% ear drops, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2022, with a ceiling value of $3,509.19 and a completion date of December 12, 2022. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (the parent company of...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FP8K0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,594.16 firm-fixed-price delivery order is for OFLOXACIN 0.3% EAR DROPS 10ML, with a completion date of September 13, 2022. The contract is not designated as a set-aside.

Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 9:57 AM